Goldman Sachs Group Inc Abbott Laboratories Call Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $1.61 Million - $1.9 Million	16,100 Added 40.15%	56,200 $6.41 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $8.29 Million - $9.25 Million	-82,300 Reduced 67.24%	40,100 $4.17 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $8.86 Million - $9.79 Million	-80,900 Reduced 39.79%	122,400 $13.9 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $4.83 Million - $5.91 Million	53,500 Added 35.71%	203,300 $22.4 Million
Q3 2023 May 14, 2024	SELL	$95.53 - $114.62 $5.11 Million - $6.13 Million	-53,500 Reduced 26.32%	149,800 $14.5 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $917,088 - $1.1 Million	9,600 Added 6.85%	149,800 $14.5 Million
Q2 2023 May 14, 2024	BUY	$100.78 - $112.29 $6.79 Million - $7.57 Million	67,400 Added 92.58%	140,200 $15.3 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $6.79 Million - $7.57 Million	67,400 Added 92.58%	140,200 $15.3 Million
Q1 2023 May 14, 2024	SELL	$96.86 - $114.01 $26.9 Million - $31.7 Million	-278,000 Reduced 79.25%	72,800 $7.37 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $26.9 Million - $31.7 Million	-278,000 Reduced 79.25%	72,800 $7.37 Million
Q4 2022 May 14, 2024	SELL	$95.06 - $111.52 $893,564 - $1.05 Million	-9,400 Reduced 2.61%	350,800 $38.5 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $893,564 - $1.05 Million	-9,400 Reduced 2.61%	350,800 $38.5 Million
Q3 2022 May 14, 2024	SELL	$96.76 - $112.03 $2.83 Million - $3.27 Million	-29,200 Reduced 7.5%	360,200 $34.9 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $2.83 Million - $3.27 Million	-29,200 Reduced 7.5%	360,200 $34.9 Million
Q2 2022 May 14, 2024	BUY	$102.07 - $123.37 $19 Million - $23 Million	186,100 Added 91.54%	389,400 $42.3 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $17.3 Million - $20.9 Million	169,500 Added 77.08%	389,400 $42.3 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $3.04 Million - $3.71 Million	-26,700 Reduced 10.83%	219,900 $26 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $9.49 Million - $11.6 Million	82,100 Added 49.91%	246,600 $34.7 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $19.2 Million - $21.2 Million	164,500 New	164,500 $19.4 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$18.9 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$14.8 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.65 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.42 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.01 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account